BIONET Statistics

Total Valuation

BIONET has a market cap or net worth of TWD 3.66 billion. The enterprise value is 3.24 billion.

Market Cap	3.66B
Enterprise Value	3.24B

Important Dates

The last earnings date was Friday, May 9, 2025.

Earnings Date	May 9, 2025
Ex-Dividend Date	Sep 19, 2024

Share Statistics

BIONET has 50.83 million shares outstanding. The number of shares has increased by 0.19% in one year.

Current Share Class	50.83M
Shares Outstanding	50.83M
Shares Change (YoY)	+0.19%
Shares Change (QoQ)	-1.85%
Owned by Insiders (%)	9.39%
Owned by Institutions (%)	0.19%
Float	40.37M

Valuation Ratios

The trailing PE ratio is 47.63.

PE Ratio	47.63
Forward PE	n/a
PS Ratio	3.01
PB Ratio	1.58
P/TBV Ratio	2.97
P/FCF Ratio	n/a
P/OCF Ratio	32.99
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 39.71, with an EV/FCF ratio of -11,080.32.

EV / Earnings	42.27
EV / Sales	2.66
EV / EBITDA	39.71
EV / EBIT	79.51
EV / FCF	-11,080.32

Financial Position

The company has a current ratio of 4.43, with a Debt / Equity ratio of 0.04.

Current Ratio	4.43
Quick Ratio	4.15
Debt / Equity	0.04
Debt / EBITDA	1.23
Debt / FCF	-342.41
Interest Coverage	31.37

Financial Efficiency

Return on equity (ROE) is 2.42% and return on invested capital (ROIC) is 1.20%.

Return on Equity (ROE)	2.42%
Return on Assets (ROA)	0.91%
Return on Invested Capital (ROIC)	1.20%
Return on Capital Employed (ROCE)	1.52%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.43
Inventory Turnover	6.77

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +7.54% in the last 52 weeks. The beta is 0.50, so BIONET's price volatility has been lower than the market average.

Beta (5Y)	0.50
52-Week Price Change	+7.54%
50-Day Moving Average	75.69
200-Day Moving Average	88.73
Relative Strength Index (RSI)	44.05
Average Volume (20 Days)	168,357

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BIONET had revenue of TWD 1.22 billion and earned 76.54 million in profits. Earnings per share was 1.51.

Revenue	1.22B
Gross Profit	681.18M
Operating Income	40.69M
Pretax Income	80.31M
Net Income	76.54M
EBITDA	70.43M
EBIT	40.69M
Earnings Per Share (EPS)	1.51

Full Income Statement

Balance Sheet

The company has 1.58 billion in cash and 99.98 million in debt, giving a net cash position of 1.48 billion or 29.07 per share.

Cash & Cash Equivalents	1.58B
Total Debt	99.98M
Net Cash	1.48B
Net Cash Per Share	29.07
Equity (Book Value)	2.31B
Book Value Per Share	25.13
Working Capital	1.56B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 110.93 million and capital expenditures -111.22 million, giving a free cash flow of -292,000.

Operating Cash Flow	110.93M
Capital Expenditures	-111.22M
Free Cash Flow	-292,000
FCF Per Share	-0.01

Full Cash Flow Statement

Margins

Gross margin is 56.00%, with operating and profit margins of 3.35% and 6.29%.

Gross Margin	56.00%
Operating Margin	3.35%
Pretax Margin	6.60%
Profit Margin	6.29%
EBITDA Margin	5.79%
EBIT Margin	3.35%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1.41, which amounts to a dividend yield of 1.96%.

Dividend Per Share	1.41
Dividend Yield	1.96%
Dividend Growth (YoY)	9.05%
Years of Dividend Growth	4
Payout Ratio	43.31%
Buyback Yield	-0.19%
Shareholder Yield	1.76%
Earnings Yield	2.09%
FCF Yield	-0.01%

Dividend Details

Stock Splits

The last stock split was on September 19, 2024. It was a forward split with a ratio of 1.070923771.

Last Split Date	Sep 19, 2024
Split Type	Forward
Split Ratio	1.070923771

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a